Chronically activated microglia contribute to the development of neurodegenerative diseases such as Alzheimer's disease (AD) by the release of pro-inflammatory mediators that compromise neuronal function and structure. Modulating microglia functions could be instrumental to interfere with disease pathogenesis. Previous studies have shown antiinflammatory effects of acetylcholine (ACh) or norepinephrine (NE), which mainly activates the b-receptors on microglial cells. Non-invasive vagus nerve stimulation (nVNS) is used in treatment of drug-resistant depression, which is a risk factor for developing AD. The vagus nerve projects to the brainstem's locus coeruleus from which noradrenergic fibers reach to the Nucleus Basalis of Meynert (NBM) and widely throughout the brain. Pilot studies showed first signs of cognitive-enhancing effects of nVNS in AD patients. In this study, the effects of nVNS on mouse microglia cell morphology were analyzed over a period of 280 min by 2-photon laser scanning in vivo microscopy. Total branch length, average branch order and number of branches, which are commonly used indicators for the microglial activation state were determined and compared between young and old wildtype and amyloid precursor protein/presenilin-1 (APP/PS1) transgenic mice. Overall, these experiments show strong morphological changes in microglia, from a neurodestructive to a neuroprotective phenotype, following a brief nVNS in aged animals, especially in APP/PS1 animals, whereas microglia from young animals were morphologically unaffected.
Alzheimer's disease (AD) is the most common cause of dementia in the elderly, affecting about 1/3 of people at or over the age of 85, currently affecting 31 million patients worldwide (Association A et al. 2017) . The underlying causes of AD remain elusive to date, but associations have been found between b-amyloid deposits (Ab), neurofibrillary tangle formation, neuroinflammation, and disease progression. As age is the main risk factor for AD, the large aging population will lead to even higher numbers of people suffering from AD in the near future (Kandel 2013) . Therefore, understanding disease pathogenesis and finding new treatments for AD is of utmost importance. The locus coeruleus (LC) is an aminergic brain stem nucleus, which is located at the tegmentum of the 4th ventricle, and represents the main source of norepinephrine (NE) in the brain. Axons project from there into all brain areas, with the neocortex and hippocampus receiving the major part of these projections.
Physiologically, LC-derived NE plays a vital role in arousal, attention, learning, and behavioral adaptation. In addition to its role as a classical neurotransmitter, NE also functions as an immune modulator, inducing the neuroprotective action of microglia and suppressing the detrimental release of proinflammatory mediators . The LC suffers from declining cell numbers in aged mammalian brains, but the loss of LC neurons is even greater in AD patients. LC neuron loss correlates with neurofibrillary tangle load, Ab plaque deposition, and the severity of dementia (Bondareff et al. 1987) . Loss of LC neurons correlates better with the progression of AD than the degeneration of the Nucleus Basalis of Meynert (NBM), which is a cholinergic nucleus and commonly associated with AD pathology (F€ orstl et al. 1994; Zarow et al. 2003) . Experimentally induced LC degeneration and subsequent decline of NE levels in its projection areas resulted in increased microglial and astrocyte immune activation, compromised microglial phagocytosis and clearance of Ab (Kalinin et al. 2007; Heneka et al. 2010; Jardanhazi-Kurutz et al. 2010 . A key feature of microglial activation in response to pathological stimuli is process retraction and overall reduction in process length. In addition, the cell soma volume increases and the overall shape of the cell becomes oval. In this state, physiological microglial functions, including surveillance and removal of debris, are strongly compromised because of the overall reduction in the environmental space scanned by the individual cell (Ransohoff 2016) . Pharmacologically, the elevation of cerebral NE levels by treatment of rodents with the NE precursor L-threo-DOPS allows resetting of microglial key functions such as migration and Ab phagocytosis . Vagus nerve stimulation (VNS) has been shown to increase NE (Hassert et al. 2004; Roosevelt et al. 2006; Follesa et al. 2007; Raedt et al. 2011) in the brain within minutes after stimulation, as measured by high-performance liquid chromatography. Furthermore, different anatomical studies have shown that VNS also activates the central cholinergic system (Smiley et al. 1999; Hays 2016; Hulsey et al. 2016 ) and its efficacy is reduced when scopolamine is used to block muscarinic receptors (Nichols et al. 2011) . Direct increase in acetylcholine (ACh) brain levels following VNS remains to be explored in further animal studies though. Moreover, the increase in these neurotransmitters caused a reduction in cytokine secretion in macrophages and T cells (Rosas-Ballina et al. 2011; Vida et al. 2011) . In addition, it was shown that an intact LC (Krahl et al. 1998; Grimonprez et al. 2015) and NBM (Hulsey et al. 2016 ) is required for the non-invasive VNS (nVNS) effect confirming that not only NE but also ACh plays an important role in the mechanism of nVNS.
Therefore, this study assessed whether such a nonpharmacological intervention would be able to revert the morphological signs of microglial activation in a murine AD model. Wild-type (WT) and amyloid precursor protein (APP)/presenilin 1 (PS1) transgenic animals, also expressing CX3CR1-EGFP to visualize brain microglia, were analyzed by 2-photon laser scanning in vivo microscopy (2PLSM), allowing an assessment of dynamic cellular changes in a longitudinal manner. Mice were investigated at 6 and 12 months of age, to determine age-dependent and diseaserelated changes. Dynamic morphological changes were recorded at identical positions over time and the number of branches, total branch length, and the average branch order were analyzed. Cranial window placement A cranial window was placed into the right hemisphere and fixed with a titanium ring for stable 2PLSM image acquisition as previously described (Holtmaat et al. 2009; Hefendehl et al. 2012) . Mice received an intraperitoneal injection (i.p.) of ketamine/xylazine (0.13/0.01 mg/g body weight), followed by subcutaneous injections (s.c.) of buprenorphine (10 lL/10 g body weight), dexamethasone (10 lL/10 g body weight), and cefotaxime (10 lL/10 g body weight). Bepanthene eye ointment was applied to the eyes to avoid drying. The surgical instruments were sterilized in a bead heater (Germinator TM 500; CellPoint Scientific Inc. Gaithersburg, MD, USA). The hair was removed using VEET â depilatory cream. The mouse was then put into a stereotactic frame and antiseptic was applied on the skin of the head. The disinfected skin was then removed using sharp scissors. One drop of 2% xylocaine and 1 : 100 000 epinephrine solution was applied both to the periosteum and the uncovered muscles. The periosteum was then removed by gently scraping with a scalpel to increase the gluing capacity between the ring and the skull. A wall of cyanoacrylate was prepared around the location and a 4 mm diameter hole was carefully drilled over the right hemisphere in a parietal position using a Schick C2 drilling device at~500 g next to the sagittal suture. The drilling device was constantly cooled with a 154 mmol/ L sodium chloride solution. The loose bone was gently removed with sharp forceps. Venus flow glue was put onto a small needle and applied around the drilled hole at a distance of 1 mm to avoid touching the dura. A 5 mm coverslip was put on top. Subsequently, the coverslip was pressed with forceps to achieve the smallest brain to coverslip distance possible, followed by exposure to blue light for 30 s to harden the glue. Next, the edges of the coverslip were fixed by putting cyanoacrylate on the bottom part of a custom-made titanium ring, which was placed on the head. The outer parts were attached to the skull using Harvard semi-implant cement. After the operation, the mouse was put under infrared light for recovery. The body temperature was controlled throughout the procedure and maintained at 37°C. Implantation of the cranial window was trained at different laboratories in Germany specialized in cranial window operations (Institutes of Physiology in Bonn and in T€ ubingen). We performed a repeated measures analysis to minimize the number of animals needed. Anesthetics and opioids as well as non-steroidal anti-rheumatics were used to reduce animal pain during and after surgery. nVNS was performed under isoflurane anesthesia.
Materials and Methods

Materials
In vivo 2PLSM imaging A Ti:Sapphire 2-photon laser scanning microscope was used with a Nikon water-immersion objective (259, 1,10 NA) and Nikon NIS Elements AR 4.20.03 (Build 995; D€ usseldorf, Germany). Imaging was performed under general volatile isoflurane anesthesia (1.2-1.5%, flow~750 mL/min). No randomization was performed, the mice were arbitrary assigned for the treatment, and every day animals from each treatment group were used for the imaging and analysis. However, the experimenter was blinded for the treatment of the mice. The hair at the right side of the neck was removed using VEET â depilatory cream for later application of nVNS or sham treatment. The mouse was put onto a heating blanket and rectal temperature was kept constant at 37°C. All images were taken using 925 nm for EGFP. An overview image was taken to help with orientation, before three zoomed areas of interest were randomly chosen and their positions saved within the Nikon NIS Elements software. The acquired stacks in 300 lm depth consisted of 81 slices covering 120 9 120 9 40 lm (x 9 y 9 z) and 0.5 lm zspace between two adjacent slices. Three stacks per time-frame were taken, resulting in a total of 21 stacks. The images were acquired under 49 line averaging technique and 4.348x scanner zoom. The voxel matrix was 512 9 512 940 pixels and the voxel size 0.234 lm/pixel. After imaging, the mouse was put back into a heated cage under infrared-light.
Non-invasive vagus nerve stimulation
After 80 min of recording and establishing two baseline stacks of three different regions, nVNS or sham treatment was performed by applying electrolyte gel (Signa gel; Parker Laboratories, Inc., Fairfield, NJ, USA) onto the stimulator's electrodes. nVNS was performed 13 mm anterior to the neck's base and 2 mm from the trachea over the vagus nerve ( Figure S1 ) similar to the placement position in rats (Oshinsky et al. 2014; Ay et al. 2016) . Using the same signal and a similar protocol as used in previous VNS animal studies (Oshinsky et al. 2014; Ay et al. 2016) , the mouse was stimulated twice for 2 min with a 3-min break in between. The nVNS signal consisted of 1 ms duration bursts of 5 kHz sine waves, repeated at 25 Hz. The signal amplitude was increased until there was strong muscle stimulation, corresponding to approximately 1.8 mA. After the stimulation or sham treatment, the same three regions were imaged another five times. Sham treatment was performed in the same manner as the nVNS only without turning on the stimulator.
Quantification of morphological cell parameters
Bitplane Imaris v8.1.2 [Jun 3 2015] Build 36825 was used to create a three-dimensional automatic reconstruction of the acquired stacks ( Figure S2 ). The following recommended automatic reconstruction settings by Imaris were used: Autopath (no loops), largest branch diameter: 11.7 lm, thinnest branch diameter: 0.704 lm, diameter of sphere region(s): 23.5 lm, automatic starting points threshold and automatic seed points threshold. The number and position of starting points (= microglia cell bodies) was kept constant within the seven timeframes of one region. The parameters for number of branches, total branch length, and average branch order were then exported as an Excel-file and further analyzed.
Statistical analysis
The R statistical software package (R Core Team 2016) was used to perform a linear mixed effects model analysis, as seven repeated measures from a single mouse were obtained with varying numbers of microglial cells, ranging from n = 31 to 76. ( Figure S3 ). Since we did not have information about the predicted variables, the sample size was not calculated before. The random effect with random intercept was mouse to account for inter-individual variation, and as fixed effects we used time (per 40 min, time-frames 1 to 7), treatment (factor of 2: nVNS or sham treatment), age (factor of 2: 6 or 12 months) and genotype (factor of 2:
. Next, the nlme package (Pinheiro et al. 2017 ) was used to fit our linear mixed effects model and the lsmeans package (Lenth 2016) to compare the least squares means between different groups. The model was fit using maximized log-likelihood. The family wise error rate was taken into account and p-values, standard errors, and confidence intervals were adjusted for multiple comparisons (see tables for adjustmentmethods). Note that our response variables were square-rooted for the analysis to account for heteroscedasticity ( Figure S4 ) and then back-transformed after calculating the least squares means. Therefore, all means, standard errors, and confidence intervals were averaged over the seven observations or 280 min in each group. In addition to the square root transformation, we used the weights argument in the lme-function to define the within-group heteroscedasticity structure. To produce 'exact' Tukey adjustment (Lenth 2016) , multivariate t distribution (mvt) and a Monte-Carlo method (Genz and Bretz 2002) were used. To attain reproducible results, the random-number seed within R was set to 0. The data are expressed as mean AE SEM.
Results
It is widely accepted that microglia, observed in age or chronic inflammation, show fewer and shorter branches compared to physiologically ramified microglia that are usually present in the healthy CNS. We used a linear mixed effects model to analyze the interactions of the four factors time, genotype, age, and stimulation on the response variables, total branch length, number of branches, and the average branch order, which are parameters that describe the ramification of microglial cells. The data predict an age-(p = 0.044) and stimulation-dependent morphological change (p = 0.001) over time. In addition, the effects of nVNS were slightly but significantly (p = 0.024) different between the young and old animals. The data suggest no genotype-related morphological changes over time (Table S1 ). Before the nVNS-induced changes in microglial morphology were elaborated, the changes between age-or genotype-matched groups were assessed, as non-nVNSrelated alterations would make any further interpretation more challenging. The obtained data revealed no significant differences for time-dependent morphology changes for all three response variables across all groups (Tables S2) . Next, we assessed the microglial morphology in age-and genotype-matched groups and compared nVNS mice with shamtreated controls. The nVNS or sham treatment was performed 80 min after starting in vivo 2PLSM, enabling the detection of differences in morphology dynamics upon nVNS during the subsequent 200 min of image acquisition. Each time point in the diagrams represents a time-frame of 40 min, e.g., 160 min is the period between 160 and 200 min of image acquisition. We calculated least squares means of the trends and compared stimulated with sham-treated mice within ageand genotype-matched groups. The differences in the slopes of the linear regression lines ( Fig. 1 and Figure S5 : dotted lines in c, d and e) of nVNS and sham-treated mice were calculated and analyzed. nVNS in 12-month-old APP/PS1 mice caused a significant difference in the time-dependent changes in branch number (p < 0.001) compared to shamtreated littermates, increasing the difference in number of branches between nVNS and sham-treated controls by 3.82 AE 0.90 branches every 40 min. There was a nonsignificant trend for 12-month-old WT mice (p = 0.071; Fig. 1c and f) in which the difference in branch number increased by 2.07 AE 0.88 every 40 min (Table 1) . nVNS stimulation in both 6-month-old groups showed no difference (Figure S5c and f; Table 1 ). Alterations in microglial morphology were further assessed by dynamic recording of total branch length in the 3D microglia reconstructions.
Again, the 12-month-old APP/PS1 groups had a significant difference in total branch length dynamics (p < 0.01; Fig. 1d and g), with an increasing difference in the total branch length between nVNS and sham-treated mice of 41.77 AE 12.31 lm (Table 2) . Correspondingly, the 12-month-old WT animals had a similar non-significant trend (p = 0.091; Fig. 1d and g ), where the average difference between nVNS and sham-treated mice increased by 30.82 AE 13.61 lm in total branch length every 40 min ( Table 2 ). The young animals showed no difference between stimulated and sham-treated mice (Table 2 ). Average branch order is a parameter for measuring branching tree complexity and is usually associated with surveying healthy microglia. In contrast to the results obtained for branch number and total branch length, a significant difference in the average branch order dynamics between stimulated and sham-treated mice (p < 0.05; Fig. 1e and h) became apparent in the WT 12-month-old group, where the difference in branch order between the nVNS and sham-treated group increased by 0.64 AE 0.25 every 40 min (Table 3 ). The 12-month-old APP/PS1 group had a non-significant trend (p = 0.0897, Fig. 1e and h ) toward increasing the difference in branch order by 0.47 AE 0.21 every 40 min (Table 3) . No differences were found between stimulated and sham-treated mice in the 6-month-old groups (Table 3) .
Discussion
Microglia cells represent a key part of the brain's innate immune system and are involved in several physiological and pathophysiological processes aimed at the maintenance of brain homeostasis and integrity throughout our lives. These cells show a distinct morphology with multiple processes and branches, which enable them to scan and survey their immediate environment (Ransohoff 2016) . Multiple contacts are constantly made between neurons and microglia, e.g., during early development to prune and scale synaptic contacts (Miyamoto et al. 2013) . However, during aging and moreover in response to pathological processes, these cells undergo fundamental changes resulting in process retraction and reduction in branch numbers (Hoeijmakers et al. 2016) . In this study, morphological changes in microglia were analyzed in wild-type and APP/PS1 transgenic mice, a murine model of AD, by 2-photon laser scanning live microscopy. Moreover, the effects of nVNS were measured longitudinally in both conditions. The results of this study suggest that morphological signs of microglial aging and activation can be reversed by nVNS. Physiological aging is associated with immune senescence, which is reflected in the brain by a switch from a resting, surveying to an activated microglial phenotype. Healthy microglial cells do not only have better Ab phagocytosis capabilities, but also release neurotrophic factors, e.g., Brainderived neurotrophic factor (BDNF) and Basic fibroblast growth factor (bFGF), and anti-inflammatory cytokines such as IL-4, IL-10, and Transforming Growth Factor beta (TGFb). Activated microglial cells on the other hand release pro-inflammatory cytokines, e.g., IL-1b, IL-6, and tumor necrosis factor alpha (TNFa) and have reduced Ab clearance. Some authors further distinguish between dystrophic microglia as observed in the aging brain and reactive hypertrophic microglia in acute injuries (Ransohoff 2016) . Both resemble the activated phenotype with retracted and fewer branches compared to long ramified branches in the healthy state (Ransohoff 2016) . Hoeijmakers et al. (2016) suggested a two-hit mechanism similar to that seen in tumor pathogenesis: an initial event like a neonatal infection or aging leads to primed microglia which are then susceptible to systemic infection or immune challenges. As a consequence, the microglia cells retract their processes and secrete proinflammatory cytokines. It is suggested that in the case of AD, increasing Ab levels lead to a neuroinflammatory environment, resulting in neurotoxicity with subsequent cognitive decline (Ransohoff 2016) . For now, the exact chronological order of pathological mechanisms remains elusive.
Our results show that 12-month-old APP/PS1 animals with greater Ab plaque deposition, benefited more from nVNS than wild-type or 6-month-old APP/PS1 animals. A recent paper has demonstrated that the activation of a7 nicotinic acetylcholine receptors (a7nAChR) is able to reverse the Lipopolysaccharides (LPS)-induced microglia conversion to an activated state. This general mechanism is often referred to as the cholinergic anti-inflammatory pathway (Zhang et al. 2017 ). It's reasonable to suggest that the microglia phenotype changes seen in this study might be the result of anti-inflammatory pathway activation. Previous studies have shown that LC-degeneration precedes that of the NBM in AD patients (F€ orstl et al. 1994; Zarow et al. 2003) . Moreover, patients with dementia and a history of depression have a significantly greater loss in LC neurons but also a slightly higher NBM neuronal density (F€ orstl et al. 1994) . In our case, we assume that in the 12-month-old APP/PS1 animals the immediate response to nVNS, subsequent NBM activation (Hulsey et al. 2016) and ACh release alter the morphological phenotype of the microglia cells. The LC also modulates the effect of nVNS -indeed LC neurons project to the NBM and this mechanism of interaction has already been suggested . A study on trigeminal allodynia in rats showed no significant differences following nVNS in the levels of NE but an increase in glutamate levels in trigeminal nucleus caudalis (Oshinsky et al. 2014) . LC activity, however, was significantly increased for up to 3 days after nVNS (Dorr and Debonnel 2006) , whereas NE levels only persisted during the stimulation-periods (Roosevelt et al. 2006) . Recently, Hulsey et al. (2017) characterized LC activity following VNS.
These findings support the hypothesis, that there is a tonic modulatory effect of LC, which does not only rely on NE as a neuromodulator (Fig. 2) . The 12-month-old WT animals also showed increasing average branch order compared to sham-treated controls. As in our case, the 6-month-old mice did not react to nVNS, thus age is a more crucial stimulus for priming microglia than the APP/PS1 phenotype with the early Ab-deposition. These conclusions are valid under the assumption that primed microglia are more susceptible to nVNS-mediated morphology changes than healthy ramified microglia. Ramified microglia are constantly surveying their environment and secrete neurotrophic factors in a healthy brain, whereas this ability may be lost in primed microglia in the senescent brain, especially in mice expressing the APP/PS1 gene (Daria et al. 2017) . Our data show for the first time that morphological changes in activated microglia may be directly reversed by nVNS. This mechanism may involve nVNS activation of LC and release of NE since LC degeneration in APP/PS1 mice increases Ab plaque deposition which triggers microglia priming (Phillips et al. 2016) . We hypothesize that stimulation of the vagus nerve increases activation of the LC and NBM, which leads to higher levels of NE and ACh, respectively, in the brain, which in turn might account for the reversed microglia phenotype. However, we cannot rule out the contribution of other excitatory mechanisms.
nVNS therapeutic range
There are two concerns regarding nVNS and the proposed underlying mode of action. First, the homomeric a7nAChR shows rapid desensitization when exposed to high levels of receptor agonists. It can even lead to cytotoxicity in exposure to high levels of ACh in the presence of an allosteric modulator, probably mediated by Ca 2+ overload (Han et al. 2017) . Second, VNS seems to work best with moderate intensity stimulation compared with lower and higher intensity stimulation during memory-enhancing treatment (Hays 2016) . The inter-individual differences in skin conductivity or thickness of the fat tissue and the skin make a physiological, molecular or radiological marker for nVNSdependent activation necessary. Recently, MRI (Yakunina et al. 2017) has been shown to be a promising method to obtain individually tailored stimulations. In contrast to the anti-inflammatory effects of NE, an inverted-U relationship (Yerkes-Dodson law) is seen between nVNS intensity and cognitive-enhancing effects (Hays 2016) . A first cognitiveenhancing effect of nVNS in AD patients was seen in a pilot study (Sj€ ogren et al. 2002) and the 1-year follow-up results (Merrill et al. 2006) . Our focus in this study was to analyze the non-invasive, transcutaneous excitation of the vagus nerve and the subsequent effects on microglia cell morphology. The amplitude of the signal was determined by increasing voltage until moderate muscle contraction was observed as described in previous studies in rat with a similar The most prevalent neurotransmitters here are Norepinephrine (NE) and Acetylcholine (ACh). The suggested target on microglia cells for ACh is the a7nAChR, whereas NE mainly activates b1 and b2 receptors. The activation of these pathways is associated with a general anti-inflammatory response. Healthy microglia have better Ab phagocytosis capabilities and increased release of neurotrophic factors (BDNF, bFGF), and anti-inflammatory cytokines (IL-4, IL-10, TNFb). These surveying microglia (represented on the left side of the figure in blue) which typically show long, ramified branches also help pruning of neuronal synapses. During aging, and even more in addition to external (infections, acute traumata) or internal (Ab deposition, stress, depression) stimuli, microglia cells get primed or even chronically activated. This leads to neuroinflammation and a toxic environment in which pro-inflammatory cytokines (IL1-b, IL-6, TNFa) of the now amoeboid cells with retracted processes get released (represented on the right side of the figure in red). This proinflammatory environment can lead to extensive neuronal loss and in the end dementia.
stimulation Chen et al. 2016 (Heneka et al. 2002 (Heneka et al. , 2003 . A persistent activation of microglia on the other hand can lead to a self-regulating cytokine cycle and eventually chronic neuroinflammation (Griffin et al. 1998; Campbell 2004) . Early anti-neuroinflammatory treatment could prevent microglia from entering this self-regulating pro-inflammatory cytokine cycle, lead to delayed AD progression and in the end, reduce cognitive decline. Anti-neuroinflammatory treatment has to begin early, as neurons are usually irreversibly destroyed in advanced AD (Kandel 2013) . Interestingly, only the old animals in this study showed morphological changes owing to nVNS. It is possible that the healthy microglia cannot be improved by nVNS, as they already show a surveying, healthy phenotype with long, maximally ramified branches and secrete neurotrophic factors. On the other hand, primed or activated microglia are more susceptible to changes in morphological parameters as a result of nVNS, as the branching parameters already lie in the bottom end of the scale. Amoeboid, activated phenotype microglia seem to be more susceptible to direct current brain stimulation as they are better equipped with voltage gated ion channels compared with ramified microglia (Gellner et al. 2016) . Depression, a risk factor for developing AD, is commonly treated with Selective serotonin reuptake inhibitors and Serotonin-norepinephrine reuptake inhibitors which in recent studies revealed an antiinflammatory modulation of microglial cells (Tynan et al. 2012; Dubovick y et al. 2014; Mourao et al. 2016) . The interplay between nVNS, LC, NBM, and its neurotransmitters remain elusive to this day. However, in a human study using VNS paired with tones to treat chronic tinnitus, patients who were on medication that included a muscarinic antagonist, a norepinephrine agonist, and a Υ-amino butyric acid agonist, which could interfere with acetylcholine and norepinephrine release, failed to benefit from VNS (De Ridder et al. 2014; Engineer et al. 2017) . A controversial effect of ATP can be seen in mice following an acute injury, as it causes process retraction in a LPS-activated microglial cell but a process induction in a resting microglial cell (Gyoneva et al. 2014) . We tried to concentrate our discussion on the interplay of these components, as many recent papers focus on the immediate effects of ACh without considering chronic, modulating NE effects. Long-term treatment options are more likely to arise from proper balance of both, the modulatory, tonic noradrenergic (O'Donnell et al. 2012 ) and the acute cholinergic anti-inflammatory systems (Han et al. 2017) (Fig. 2) . Future studies using blockers of NE or ACh (e.g., N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine, a selective NE-neurotoxin or methyllycaconitine an ACh antagonist), might reveal the mechanism behind nVNS. In the case of epilepsy, previous studies indicate NE as the primary neuromodulator accounting for the protective effects of nVNS, thus suggesting a primary role for LC activation (Roosevelt et al. 2006; Vonck et al. 2014) . The imminent effects on microglia cell morphology seem to be mediated by a7nAChR activation. The morphological responses to nVNS and ACh release in a NE enriched and a NE depleted environment have yet to be explored. Our results give a first glance at a stabilizing effect of nVNS on microglia morphology. We need further studies with transcriptomic and proteomic analyses though to find the exact mechanisms of action behind a potential reversion of activated microglia after nVNS.
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